UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/13/2779087/27423/en/UPDATE-Galectin-Therapeutics-Reports-Financial-Results-for-the-Quarter-Ended-September-30-2023-and-Provides-Business-Update.html

NORCROSS, Ga., Nov. 13, 2023 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three months ended September 30, 2023. These results are included in the Company’s Quarterly Report on Form 10-Q, which has been filed with the U.S. Securities and Exchange Commission and is available at www.sec.gov.

Read more at globenewswire.com

Related news for (GALT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.